Objectives To evaluate the accuracy of the Fetal Medicine Foundation (FMF) triple test, a competing risk model, in predicting preterm pre-eclampsia (PE) in a Spanish cohort. Methods A prospective cohort study was conducted in eight fetal-medicine units in five Spanish regions from September 2017 to December 2019. Pregnant women with singleton pregnancies and non-malformed live fetuses attending their routine ultrasound examination at 11+0 to 13+6 weeks of gestation were included.